Showing results (121-130 of 130) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2020
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC TrialEva Versteijne, Mustafa Suker, Karin Groothuis, et al.European Journal of Cancer (Oxford, England : 1990)|July 14, 2026
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancerNicole D Hildebrand, David P J van Dijk, Jisce R Puik, et al.BMJ Open|July 16, 2025
STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II studySuus Y van Loosbroek, Maaike T W Milder, Dirk de Ruysscher, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 24, 2019
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysisTara M Mackay, F Jasmijn Smits, Daphne Roos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC TrialEva Versteijne, Jacob L van Dam, Mustafa Suker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 TrialRuth A L Willems, Aniek E van Diepen, Esther N Dekker, et al.JAMA Surgery|February 14, 2024
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical TrialTara M Mackay, Anouk E J Latenstein, Simone Augustinus, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohortMarieke S Walma, Lilly J Brada, Susana I S Patuleia, et al.JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.The Lancet. Oncology|September 13, 2025
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trialQuisette P Janssen, Jacob L van Dam, Marlies L van Bekkum, et al.Pageof 13